Table 2.
(a) | |||
---|---|---|---|
| |||
GENE | POLYMORPHISM | VARIANT ALLELES | RISK ALLELE |
Dopamine D1 Receptor DRD1 |
rs4532 | A/G | A |
Dopamine D2 Receptor DRD2 |
rs1800497 | A/G (A1/A2) |
A (A1) |
Dopamine D3 Receptor DRD3 |
rs6280 | C/T | C |
Dopamine D4 Receptor DRD4 |
rs1800955 | C/T | C |
Catechol-O-Methyltransferase COMT |
rs4680 | A/G (Met/Val) |
G (Val) |
Mu-Opioid Receptor OPRM1 |
rs1799971 | A/G (As/Asp) |
G (Asp) |
(b) | |||
GENE | POLYMORPHISM | VARIANT ALLELES | RISK ALLELE |
| |||
Dopamine D4 Receptor DRD4 |
rs761010487 | 48bp repeat 2R - 11R |
≥7R, long form |
Dopamine Active Transporter DAT1 |
rs28363170 | 40p repeat 3R - 11R |
< 9R |
Monoamine Oxidase A MAOA |
rs768062321 | 30bp repeat 2R - 5R |
3.5R, 4R, 5R |
Serotonin Transporter SLC6A4 (5-HTTLPR) |
rs4795541, rs25531 |
43bp repeat, with SNP L/XL and S, G/A |
S, LG |
(c) | |||
GENE | POLYMORPHISM | VARIANT ALLELES | RISK ALLELE |
| |||
GABA(A) Receptor, Alpha-3 GABRB3 |
rs764926719 | CA dinucleotide repeat 171 – 201bp sized fragments |
181 |